Get started
Author

Markhabat Kassenov

Observed names: M. Kassenov, M. M. Kasenov, M. M. Kassenov, M.M. KASSENOV, M.M. KASSENOV¹, M.M. Kasenov, M.M. Kassenov, Marhabat Kassenov, Markhabat M. Kassenov, Markhabat Melisbekovich Kassenov, М.М. KASSENOV¹, М.М. Kassenov, М.М. Касенов, Мархабат Касенов
ORCID: 0000-0001-6124-703X
Observed ORCID: 0000-0001-6124-703X
OpenAlex ID: A5023526305
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
2021 · Kunsulu Zakarya, Lespek Kutumbetov, et al. · EClinicalMedicine · 58
PDF
Efficacy and Safety of an Inactivated Whole-Virion Vaccine Against COVID-19, QazCovid-in®, In Healthy Adults: A Multicentre, Randomised, Single-Blind, Placebo-Controlled Phase 3 Clinical Trial With a 6-Month Follow-Up
2022 · Berik Khairullin, Kunsulu Zakarya, et al. · EClinicalMedicine · 36
Preclinical Evaluation of TB/FLU-04L—An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis
2023 · Anna-Polina Shurygina, Natalia Zabolotnykh, et al. · International Journal of Molecular Sciences · 29
PDF
A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies
2022 · Zhanna Buzitskaya, Kira Stosman, et al. · Drug Research · 26
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
2021 · Kuandyk Zhugunissov, Kunsulu Zakarya, et al. · Frontiers in Microbiology · 26
PDF
An Inactivated, Adjuvanted Whole Virion Clade 2.2 H5N1 (A/Chicken/Astana/6/05) Influenza Vaccine Is Safe and Immunogenic in a Single Dose in Humans
2013 · Abylay R. Sansyzbay, Marianna K. Erofeeva, et al. · Clinical and Vaccine Immunology · 17
PDF
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
2022 · Ainur Nurpeisova, Berik Khairullin, et al. · Human Vaccines & Immunotherapeutics · 14
Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health
2024 · Zhandos Abay, Sandugash Sadikaliyeva, et al. · Viruses · 12
Comparison of Different Methods of Purification and Concentration in Production of Influenza Vaccine
2017 · N. N. Asanzhanova, Sh. Zh. Ryskeldinova, et al. · Bulletin of Experimental Biology and Medicine · 12
Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine
2019 · Ainur Nurpeisova, Markhabat Kassenov, et al. · Archives of Virology · 11
Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
2021 · Kuandyk Zhugunissov, Sanat Kilibayev, et al. · Frontiers in Veterinary Science · 10
PDF
Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan
2022 · Yerbol Burashev, Bekbolat Usserbayev, et al. · Microbiology Resource Announcements · 9
Seroprevalence and Molecular Analysis of Bovine Leukemia Virus in Kazakhstan
2025 · Saltanat Mamanova, Ainur Nurpeisova, et al. · Viruses · 8
PDF
Safety and immunogenicity of the novel seasonal preservative‐ and adjuvant‐free influenza vaccine: Blind, randomized, and placebo‐controlled trial
2017 · Gulbanu Sarsenbayeva, Yevgeniy Volgin, et al. · Journal of Medical Virology · 8
Development and evaluation of a multiplex polymerase chain reaction in real-time for differential diagnosis of Moraxella-induced keratoconjunctivitis in livestock
2023 · Vitaliy Strochkov, Rano Sattarova, et al. · Veterinary World · 6
PDF
Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis
2023 · Zhandos Abay, Sandugash Sadikalieva, et al. · Journal of Genetic Engineering and Biotechnology · 6
PDF
Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis
2023 · Zhandos Abay, Ainur Nurpeisova, et al. · Vaccines · 6
PDF
Serological exposure in Bactrian and dromedary camels in Kazakhstan to a MERS or MERS‐like coronavirus
2022 · Mukhit B. Orynbayev, Alan T. Hitch, et al. · Transboundary and Emerging Diseases · 6
PDF
Near-Complete Genome Sequence of an H5N1 Avian Influenza Virus Strain Isolated from a Swan in Southwest Kazakhstan in 2006
2020 · Yerbol Burashev, Vitaliy Strochkov, et al. · Microbiology Resource Announcements · 6
Bovine Viral Diarrhea in Kazakhstan
2025 · Elvira Bashenova, Raikhan Nissanova, et al. · Viruses · 5
PDF
Complete Genome Sequence of the Highly Pathogenic Strain A/Domestic Goose/Pavlodar/1/05 (H5N1) of the Avian Influenza Virus, Isolated in Kazakhstan in 2005
2020 · Aisha Issabek, Yerbol Burashev, et al. · Microbiology Resource Announcements · 5
Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults
2017 · Gulbanu Sarsenbayeva, Yevgeniy Volgin, et al. · Human Vaccines & Immunotherapeutics · 5
PDF
A novel preservative‐free seasonal influenza vaccine safety and immune response study in the frame of preclinical research
2017 · Gulbanu Sarsenbayeva, Yevgeniy Volgin, et al. · Journal of Medical Virology · 5
First report on identification of Salmonella Abortusovis from ovine abortion cases in Kazakhstan
2026 · Assiya Mussayeva, Zhandos Abay, et al. · Frontiers in Veterinary Science · 4
PDF
Blackleg in cattle in Kazakhstan: regional epizootology, seasonal patterns, and molecular identification of the pathogen
2025 · Assilbek Mussoyev, Aspen Abutalip, et al. · Frontiers in Veterinary Science · 4
PDF
Works count: 76
Citation count: 372
H-index: 10
I10-index: 11
Year
Topic
Type